TCL Archive Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival June 24, 2011
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive In Brief: Hew Finally Okays New NIH Study Section For Chemical, Environmental Carcinogenesis March 16, 1979
